Content area
Abstract
Staphylococcus aureus bacteremia (SAB) is a severe infectious disease with a heterogenous clinical presentation. To diagnose possible metastatic infection and to start early adequate management including antimicrobial treatment and adequate source control as soon as possible, guidelines recommend additional imaging such as [18F]FDG-PET/CT. In this clinical perspective, we describe the current evidence of [18F]FDG-PET/CT in SAB and we share our view on the value of [18F]FDG-PET/CT in specific SAB patients.
Details
Title
The role of [18F]FDG-PET/CT in Staphylococcus aureus bacteremia: A clinical perspective
Author
Kouijzer, Ilse J. E. 1 ; Ghanem-Zoubi, Nesrin 2
1 Radboud university medical center, Department of Internal Medicine and Radboud Community for Infectious Diseases, Nijmegen, the Netherlands (GRID:grid.10417.33) (ISNI:0000 0004 0444 9382)
2 Rambam Health Care Campus, Infectious Diseases Institute, Haifa, Israel (GRID:grid.413731.3) (ISNI:0000 0000 9950 8111); Israel Institute of Technology, The Ruth and Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel (GRID:grid.6451.6) (ISNI:0000 0001 2110 2151)
1 Radboud university medical center, Department of Internal Medicine and Radboud Community for Infectious Diseases, Nijmegen, the Netherlands (GRID:grid.10417.33) (ISNI:0000 0004 0444 9382)
2 Rambam Health Care Campus, Infectious Diseases Institute, Haifa, Israel (GRID:grid.413731.3) (ISNI:0000 0000 9950 8111); Israel Institute of Technology, The Ruth and Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel (GRID:grid.6451.6) (ISNI:0000 0001 2110 2151)
Pages
32
Publication year
2024
Publication date
Dec 2024
e-ISSN
2948197X
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3225849572
Copyright
Copyright Nature Publishing Group Dec 2024